NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 42 filers reported holding NEON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 9,741,636 | $25,718,000 | 7.00% |
| HARVARD MANAGEMENT CO INC | 505,871 | $1,335,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,050,000 | $2,772,000 | 0.17% |
| Maven Securities LTD | 381,150 | $1,006,000 | 0.12% |
| Athanor Capital, LP | 547,651 | $1,446,000 | 0.09% |
| MONETA GROUP INVESTMENT ADVISORS LLC | 102,652 | $271,000 | 0.03% |
| TERRIL BROTHERS, INC. | 19,300 | $51,000 | 0.02% |
| MEEDER ASSET MANAGEMENT INC | 5,878 | $15,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 94,908 | $251,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |